ONGENSMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Feb 2019)
What this means for you
This application is over — abandoned 11 Feb 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87673655
- Mark type
- Stylized text
- Filed
- 06 Nov 2017
- Published for opposition
- 15 May 2018
- Abandoned
- 11 Feb 2019
- Attorney of record
- Peter J. Willsey
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
Owner
- AveXis, Inc., Bannockburn, IL, US
- AveXis, Inc., Bannockburn, IL, US
Prosecution history
- 11 Feb 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Feb 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Jul 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 May 2018 — PUBLISHED FOR OPPOSITION
- 25 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Apr 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Mar 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Mar 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Feb 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Feb 2018 — NON-FINAL ACTION E-MAILED
- 23 Feb 2018 — NON-FINAL ACTION WRITTEN
- 16 Feb 2018 — ASSIGNED TO EXAMINER
- 16 Nov 2017 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED